CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


CA Cancer J Clin 1995; 45:305
doi: 10.3322/canjclin.45.5.305
© 1995 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shingleton, H. M.
Right arrow Articles by Smith, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shingleton, H. M.
Right arrow Articles by Smith, R. A.

CA: A Cancer Journal for Clinicians, Vol 45, Issue 5 305-320, Copyright © 1995 by American Cancer Society


ARTICLES

The current status of the Papanicolaou smear

H. M. Shingleton, R. L. Patrick, W. W. Johnston and R. A. Smith
American Cancer Society in Atlanta, Georgia, USA.

Since its introduction as a screen for cervical cancer in the late 1940s, the Pap smear has become one of the most widely accepted screening procedures for cancer. Numerous scientific studies have now attested to its effectiveness. However, important issues related to the Pap smear, including cytologic nomenclature, accuracy, regulatory procedures, and screening guidelines, are still being evaluated and debated. This article provides an overview of important issues related to the Pap smear.


This article has been cited by other articles:


Home page
Obstet GynecolHome page
S. Yasmeen, P. S. Romano, M. Pettinger, S. R. Johnson, F. A. Hubbell, D. S. Lane, and S. L. Hendrix
Incidence of Cervical Cytological Abnormalities With Aging in the Women's Health Initiative: A Randomized Controlled Trial
Obstet. Gynecol., August 1, 2006; 108(2): 410 - 419.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Heselmeyer-Haddad, K. Sommerfeld, N. M. White, N. Chaudhri, L. E. Morrison, N. Palanisamy, Z. Y. Wang, G. Auer, W. Steinberg, and T. Ried
Genomic Amplification of the Human Telomerase Gene (TERC) in Pap Smears Predicts the Development of Cervical Cancer
Am. J. Pathol., April 1, 2005; 166(4): 1229 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Heselmeyer-Haddad, V. Janz, P. E. Castle, N. Chaudhri, N. White, K. Wilber, L. E. Morrison, G. Auer, F. H. Burroughs, M. E. Sherman, et al.
Detection of Genomic Amplification of the Human Telomerase Gene (TERC) in Cytologic Specimens as a Genetic Test for the Diagnosis of Cervical Dysplasia
Am. J. Pathol., October 1, 2003; 163(4): 1405 - 1416.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
R. A. Smith, V. Cokkinides, A. C. von Eschenbach, B. Levin, C. Cohen, C. D. Runowicz, S. Sener, D. Saslow, and H. J. Eyre
American Cancer Society Guidelines for the Early Detection of Cancer
CA Cancer J Clin, January 1, 2002; 52(1): 8 - 22.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. F. Sawaya, A. D. Brown, A. E. Washington, and A. M. Garber
Current Approaches to Cervical-Cancer Screening
N. Engl. J. Med., May 24, 2001; 344(21): 1603 - 1607.
[Full Text] [PDF]


Home page
CA Cancer J ClinHome page
M. F. Janicek and H. E. Averette
Cervical Cancer: Prevention, Diagnosis, and Therapeutics
CA Cancer J Clin, March 1, 2001; 51(2): 92 - 114.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. F. Sawaya, D. Grady, K. Kerlikowske, J. L. Valleur, V. M. Barnabei, K. Bass, T. E. Snyder, J. H. Pickar, S. K. Agarwal, J. Mandelblatt, et al.
The Positive Predictive Value of Cervical Smears in Previously Screened Postmenopausal Women: The Heart and Estrogen/progestin Replacement Study (HERS)
Ann Intern Med, December 19, 2000; 133(12): 942 - 950.
[Abstract] [Full Text] [PDF]


Home page
Arch Fam MedHome page
P. Curtis, M. Mintzer, D. Morrell, J. C. Resnick, S. Hendrix, and B. F. Qaqish
Characteristics and Quality of Papanicolaou Smears Obtained by Primary Care Clinicians Using a Single Commercial Laboratory
Arch Fam Med, September 1, 1999; 8(5): 407 - 413.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
M.-A. B. Shafer, R. H. Pantell, and J. Schachter
Is the Routine Pelvic Examination Needed With the Advent of Urine-Based Screening for Sexually Transmitted Diseases?
Arch Pediatr Adolesc Med, February 1, 1999; 153(2): 119 - 125.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
P. Zazove, B. D. Reed, L. Gregoire, A. Ferenczy, D. W. Gorenflo, and W. D. Lancaster
Low False-Negative Rate of PCR Analysis for Detecting Human Papillomavirus-Related Cervical Lesions
J. Clin. Microbiol., September 1, 1998; 36(9): 2708 - 2713.
[Abstract] [Full Text]


Home page
NEJMHome page
S. A. Cannistra and J. M. Niloff
Cancer of the Uterine Cervix
N. Engl. J. Med., April 18, 1996; 334(16): 1030 - 1037.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by American Cancer Society.